RDY - Dr Reddy's Laboratories Ltd (RDY) Q3 2024 Earnings Call Transcript
2024-01-30 15:50:21 ET
Dr Reddy's Laboratories Ltd. (RDY)
Q3 2024 Earnings Conference Call
January 30, 2024 10:00 AM ET
Company Participants
Richa Periwal - IR
Parag Agarwal - CFO
Erez Israeli - CEO
Conference Call Participants
Mikaela Franceschina - Barclays
Kunal Dhamesha - Macquarie
Tushar Manudhane - Motilal Oswal Financial Services
Neha Manpuria - Bank of America
Damayanti Kerai - HSBC Securities and Capital Markets India Private Limited
Surya Patra - Phillip Capital India Private Limited.
Bino P - Ilara Capital
Shyam Srinivasan - Goldman Sachs
Presentation
Operator
Ladies and gentlemen, good day, and welcome to the Dr. Reddy's Q3 FY '24 Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode, and there will an opportunity for you to ask questions after the presentation concludes. [Operator Instructions]. Please note that this conference is being recorded.
I now hand the conference over to Ms. Richa Periwal. Thank you, and over to you, Ma'am.
Richa Periwal
Thank you. A very good morning and good evening to all of you and thank you for joining us today for the Dr. Reddy's earnings conference call for the quarter ended, December 31, 2023. Earlier during the day, we've released our results and the same was also posted on our website. This call is being recorded and the playback and transcript shall be made available on our website soon.
All the discussions and analysis of this call will be based on the IFRS consolidated financial statements. The discussion today contains certain non-GAAP financial measures. For a reconciliation of GAAP to non-GAAP measures, please refer to our press release.
To discuss the business performance and outlook, we have our CEO, Mr. Erez Israeli , and our CFO, Mr. Parag Agarwal, and the entire investor relations team. Please note that today's call is a copyrighted material of Dr. Reddy, and cannot be rebroadcasted or attributed in press or media outlets without the Company's expressed written consent. Before I proceed with the call, I would like to remind everyone that the safe harbor contained in today's press release also pertains to this conference call.
Now, I hand over the call to Mr. Parag Agarwal. Over to you, Parag.
Parag Agarwal
Thank you, Richa, and greetings to everyone. A warm welcome to our quarter three, FY '24 earnings call. Thanks for joining. I'm pleased to take you through our financial performance for the quarter. For this section, all amounts have been translated into U.S. dollar as a convenience translation rate of rupees 83.19, which is the rate as of December 31, 2023....
Dr Reddy's Laboratories Ltd (RDY) Q3 2024 Earnings Call Transcript